Trade Karuna Therapeutics, Inc. - KRTX CFD

Add to favourite

329.60

0.03%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.41

Long position overnight fee

-0.023485%

Short position overnight fee

0.001262%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	329.51
Open	329.63
1-Year Change	75.95%
Day's Range	329.56 - 329.7

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Mar 15, 2024	329.60	0.03	0.01%	329.57	329.76	329.54
Mar 14, 2024	329.51	-0.05	-0.02%	329.56	329.59	329.41
Mar 13, 2024	321.75	-0.98	-0.30%	322.73	322.81	320.58
Mar 12, 2024	322.12	2.81	0.88%	319.31	322.12	319.11
Mar 11, 2024	319.00	0.24	0.08%	318.76	319.81	318.06
Mar 8, 2024	319.49	2.23	0.70%	317.26	319.55	317.26
Mar 7, 2024	317.25	-0.56	-0.18%	317.81	319.31	316.59
Mar 6, 2024	318.22	0.22	0.07%	318.00	319.55	316.48
Mar 5, 2024	318.43	0.67	0.21%	317.76	319.05	317.18
Mar 4, 2024	317.86	3.05	0.97%	314.81	318.02	314.81
Mar 1, 2024	315.98	2.20	0.70%	313.78	316.75	313.78
Feb 29, 2024	313.69	-1.12	-0.36%	314.81	315.91	313.69
Feb 28, 2024	315.34	1.03	0.33%	314.31	316.55	314.31
Feb 27, 2024	314.65	-0.11	-0.03%	314.76	317.83	313.88
Feb 26, 2024	315.69	-3.62	-1.13%	319.31	319.83	295.80
Feb 23, 2024	320.06	2.83	0.89%	317.23	320.19	317.23
Feb 22, 2024	319.06	1.00	0.31%	318.06	319.26	318.06
Feb 21, 2024	318.70	1.29	0.41%	317.41	318.72	317.41
Feb 20, 2024	318.20	0.89	0.28%	317.31	318.80	317.31
Feb 16, 2024	318.06	-0.70	-0.22%	318.76	319.60	317.22

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Karuna Therapeutics, Inc. Company profile

About Karuna Therapeutics Inc

Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on creating and delivering transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is for the treatment of psychosis in Alzheimer's disease (AD), which is the prevalent subtype of dementia-related psychosis (DRP). KarXT is a combination of xanomeline and trospium. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms associated with schizophrenia and dementia-related psychosis (DRP). Its muscarinic receptors serve a number of physiological roles, including in cognitive, behavioral, sensory, motor and autonomic processes.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Karuna Therapeutics Inc revenues increased from $0K to $37M. Net loss increased from $68.6M to $143.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $32.3M to $98.7M (expense), General and administrative - Other increase from $6.5M to $25.2M (expense).

Industry:

Bio Therapeutic Drugs

99 High Street
26th Floor
BOSTON
MASSACHUSETTS 02110
US